 |
|
|
|
|
Washington Life Science Industry Directory
Target your advertising by state, region or nationwide for the same low rate
Banner Advertising | Event Advertising
Cascadian Therapeutics Inc.
| | | | | Phone: | (206) 801-2100 | | Year Established: | 2016 | | Ticker: | SGEN | | Exchange: | NASDAQ | | | | Other Contacts: | Marc L. Lesnick, Ph.D., Senior VP, Regulatory Affairs & Quality
Scott R. Peterson, Ph.D., CSO
Luke N. Walker, M.D., VP, Clinical Development
Scott D. Myers, President & CEO
Gary W. Christianson, PE, COO
Julie M. Eastland, M.B.A., CFO VP, Corporate Development
| | | | Company Description | | Cascadian Therapeutics, formerly Oncothyreon and a Seattle Genetics subsidiary, is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients. | |
|
|
|
|
|
|
|
